Renaissance Investment Consultants Holding Company’s AbbVie ABBV Stock Holding History

Renaissance Investment Consultants Holding Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$214K	Buy	+2,285	New	+$215K	0.2%	75
2020 Q1	–	Sell	-2,427	Closed	-$215K	–	85
2019 Q4	$215K	Buy	+2,427	New	+$201K	0.24%	84

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Renaissance Investment Consultants Holding Company's ABBV Position: Q3 2020 in Review

Renaissance Investment Consultants Holding Company opened a new position in AbbVie (ABBV) in Q3 2020: 2,285 shares worth $214K. The stake represents 0.2% of the portfolio and ranks #75 among its holdings. This is a return to the name: Renaissance Investment Consultants Holding Company previously reported a position in ABBV as recently as Q4 2019.

Renaissance Investment Consultants Holding Company first reported a position in ABBV in Q4 2019 and has held it in 2 quarters since. The position peaked at $215K in Q4 2019. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

Renaissance Investment Consultants Holding Company held 2,285 shares of AbbVie worth $214K as of Q3 2020.
AbbVie was a new Renaissance Investment Consultants Holding Company position in Q3 2020.
AbbVie made up 0.2% of Renaissance Investment Consultants Holding Company's portfolio in Q3 2020, its #75 holding.
Renaissance Investment Consultants Holding Company first reported a position in AbbVie in Q4 2019 and has held it in 2 quarters since.
Renaissance Investment Consultants Holding Company's AbbVie position peaked at $215K in Q4 2019.
2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Renaissance Investment Consultants Holding Company's 13F filing for Q3 2020, filed 6 Nov 2020.